Financial & competing interests disclosure
G Döring acted as consultant for the company IMMUNO, which produced the flagella vaccine for the Phase III study. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.